| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695110 | Gynecologic Oncology | 2017 | 9 Pages |
Abstract
QC exhibited significant antitumor activity against EC in vitro and was successful as maintenance therapy in chemo-resistant EC mouse xenografts. This preclinical data suggest that QC may be an important adjunct to standard chemotherapy for patients with chemo-resistant EC.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Eleftheria MD, Debarshi Ph.D, Ashwani Ph.D, Susmita Ph.D, Amy L. MS, Xiaoping MD. Ph.D, Sean C. MD, Viji Ph.D,